Skip to main content

Closed

CELU: Celularity Inc. Financial Statements & Revenue | finqOS

Healthcare · Biotechnology

52W Range

2thpctl

Volume

0.50×avg

Market Cap

18.39MUSD

P/E Ratio

-0.2TTM

Div Yield

-ann

Celularity Inc.

CELUNASDAQ Capital Market·USD·Closed

Celularity Inc.

CELUNASDAQ·USD·Closed

$0.64

−6.57%

$0.64

−$0.04 (6.57%)

52W Range

2thpctl

Volume

0.50×avg

Mkt Cap

18.39MUSD

P/E

-0.2TTM

Div Yield

–ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings